ArticleBMC veterinary research2026
Resistance reversion after Haemonchus contortus replacement in a sheep flock: monitoring of benzimidazole and levamisole resistance-associated polymorphisms and impact on lamb survival.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHaemonchus contortus is a highly prevalent gastrointestinal nematode whose control is hindered by anthelmintic resistance. Worm replacement (WR), where a resistant parasite population is substituted for a susceptible one, was performed through an artificial infection of nematode-free ewes with a susceptible H. contortus isolate. The infected ewes were kept in a nematode-free paddock (total replacement—TR) or in a paddock naturally infested with resistant helminths (partial replacement—PR) and compared to untreated ewes kept in a naturally infested paddock (control—C). Lambs born in each group, over two breeding seasons, were evaluated from 63 to 189 days old and subjected to lifesaving anthelmintic treatments (AHt) with the combination of benzimidazole and levamisole when fecal egg counts (FEC) ≥ 10,000 and packed cell volume (PCV) ≤ 24% or when PCV ≤ 22%, and a Kaplan–Meier survival analysis of the AHt requirement was performed. Benzimidazole (F200Y) and levamisole (S168T) resistance-associated polymorphisms were genotyped in H. contortus every six months after WR.
resultsIn lambs, the FEC mean increased (4647 to 8506) and the PCV mean decreased (30.8% to 27.2%) between the first and second breeding seasons; the AHt mean in C (2.4) was higher than in TR (1.4) and PR (1.6) in the second breeding season; and inferior survival probabilities were observed in C compared to TR throughout the trial and to PR in the second breeding season. A methodology for S168T genotyping using real-time PCR and allelic discrimination with fluorescent hydrolysis probes was developed. Resistance frequencies similar to the C group for the F200Y and S168T polymorphisms, respectively, were reached after 1 and 7 months in PR and after 7 and 13 months in TR.
conclusionsThe positive effects of WR on phenotypic health traits in lambs lasted for at least two breeding seasons. However, molecular anthelmintic resistance in H. contortus was reestablished in the first year, reinforcing the role of molecular methods in the early diagnosis and monitoring of resistance. Although the resistance reversion showed a time-limited effect, WR was able to control the detrimental effects of haemonchosis in lambs born in two consecutive breeding seasons until slaughter age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.